Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Study status changed from Active, not recruiting to Completed; enrollment updated from 120 (Estimated) to 102 (Actual), with related dates adjusted accordingly.
    Difference
    0.4%
    Check dated 2025-12-02T16:43:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added and v3.2.0 removed from the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:56:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A government funding-operational notice about potential delays and NIH status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:58:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Administrative updates were posted on 2025-10-29 and 2025-10-28, including the last update timestamp and QC criteria details. Deletions dated 2025-09-17 and 2025-09-18 indicate routine record maintenance rather than changes to the study design, eligibility, or outcomes.
    Difference
    0.5%
    Check dated 2025-11-03T21:05:08.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and open status for the NIH Clinical Center, plus a new version tag v3.2.0; removed the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T07:00:19.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:48:08.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.